Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation

[摘要] Mesenchymal stromal cells (MSCs) are multipotent progenitor cells known to modulate the immune system and to promote hematopoiesis. These dual effects make MSCs attractive for use as cellular therapy in hematopoietic cell transplantation (HCT). MSCs can be used peri-HCT or pre-engraftment to modulate immune reconstitution, promoting hematopoietic stem cell (HSC) engraftment and/or preventing graft-versus-host disease (GVHD). Pre-clinical studies have demonstrated that MSCs can potentiate HSC engraftment and prevent GVHD in a variety of animal models. Clinical trials have been small and largely non-randomized but have established safety and early evidence of efficacy, supporting the need for larger randomized trials.

[发布日期] 2015-12-16

[关键词] Mesenchymal Stromal Cell;Hematopoietic Cell Transplantation;Cord Blood Transplantation;Historical Control Group;Bone Marrow MSCs